Founded in 2004, PHAR is a boutique consultancy dedicated to the practice of health services. We are physician-led, allowing us to bring both clinical experience and methodological expertise to every project. Each study commands the attention of a team of senior-level experts, ensuring flawless execution at every stage of every project.
Understanding patterns of health care use is a core aspect of health services research. Most “patterns of care” studies focus on one or more specific care component: cost of care, quality in relation to guidelines, persistence and compliance, and drug or other health service utilization. PHAR, LLC has developed a proprietary method of graphical analysis called GRAPHx to improve the interpretability of these kinds of studies. Using patient-level, high-resolution graphics, we can create single-page images that illustrate thousands of patient histories. When combined with more traditional analyses, these graphical summaries give us deeper insight into common health care practices.
The PHAR, LLC outcomes research conducts a variety of study types, including systematic literature reviews, primary data collection with retrospective or prospective patient chart reviews, physician surveys, as well as secondary data analyses using major commercial-insurance databases and other data sources. The group disseminates study findings in a variety of forums to provide payers, clinicians, and researchers with novel and timely data on a variety of important health services research topics.
In addition to our proprietary data visualization tool, we also conduct:
Articulating a strategy to demonstrate a product’s value requires careful consideration of the marketplace, a product’s attributes, and the competitive landscape. The health economic tactics needed to execute this strategy can be considered only after such a plan has been laid out. Every PHAR, LLC project begins with a careful assessment of our client’s needs, the competitive landscape and the product strategy. Our combination of clinical and economic experience then allows us to bring a big picture focus to every project, regardless of size or budget.
The health economics group at PHAR, LLC uses cost effectiveness and budget impact analyses to help clients in the life sciences industry establish value for their products. Our clinically-relevant, transparent models are populated with real world data and demonstrate to payers, clinicians, and researchers the economic and health-related impact of various technologies and products.
Our health economic services include:
The sequencing of the human genome and the development of low cost microarrays have led to a proliferation of tests of gene expression in many cancers, many of which tests are designed to predict recurrence and guide treatment. Other assays guide the selection of chemotherapeutic regimens. Medicare and private payer reimbursement of these tests depends on providing evidence of 3 types of validity: analytic validity, clinical validity, and clinical utility. PHAR, LLC has a proven track record of developing methodologically sound evidence of clinical utility for a variety of genomic tests, as well as extensive experience in developing tools to communicate these results with managed care payers.
Services relevant to the genomics industry include:
Using a well tested, rigorous method can help organizations draw on expert advisors to formulate strategy. A quantitative method, called the Delphi process, improves information gathering and decision making. This method was described in Harvard Business Review as a way to develop “highly useful strategic guidelines.” We have used it to help companies determine whether new clinical trials are likely to be worth their cost; to determine the direction of marketing campaigns; to develop classification systems and terminology for common diseases; to develop appropriateness of various treatments for a particular type of patient; and to set standards for economic analyses. In such situations, traditional processes for problem solving had not been fruitful, but the Delphi panel method was able to produce meaningful results.
Other strategic consulting services include:
Partnership for Health Analytic Research (PHAR), LLC has not received any reviews.
Partnership for Health Analytic Research (PHAR), LLC has not received any endorsements.